American Journal of Epidemiology Vol. 110, No. 2: 188-195
Copyright © 1979 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
INCREASED RISK OF THROMBOSIS DUE TO ORAL CONTRACEPTIVES: A FURTHER REPORT1
2 Reprint requests to Ms. Maguire, Department of Biostatistics, The Johns Hopkins University School of Hygiene and Public Health, 615 North Wolfe St., Baltimore, MD 21205.
In a previously reported case-control study of the relationship between oral contraceptives and thromboembolism, there were 461 cases and 1302 controls, individually matched on age, race, marital status, hospital, and date of admission. Initially, the control patients had not been matched with the cases for the presence or absence of six factors thought to predispose to or precipitate thromboembolic disease. The present paper reports the effects of taking into consideration these factors in the controls. Two methods of analysis (matched set, and logistic regression) gave closely similar results. Where the case series consisted of idiopathic cases, the revised estimate of the relative risk was reduced from 7.2 to 4.7 by these procedures; for predisposed cases, it was increased from 1.2 to 2.2. The explanation suggested in the previous report for the failure to find an increased risk for cases with predisposition receives support from these findings. Variation in the relative risk was examined for four separate diagnostic categories: venous thrombosis alone, pulmonary embolism alone, venous thrombosis and pulmonary embolism together, and myocardial infarction. The relative risk estimates were greater than unity for each thrombosis category for both predisposed and non-predisposed cases. The relative risk was not found to vary significantly according to age or smoking status.
contraceptives, oral; myocardial infarct; pulmonary embolism; retrospective studies; thromboembolism; thrombophlebitis
1 From The Johns Hopkins University School of Hygiene and Public Health, Departments of Biostatastics and Epidemiology, Baltimore, MD, and the University of Pennsylvania, School of Medicine, Department of Research Medicine, Philadelphia, PA.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. Ageno, C. Becattini, T. Brighton, R. Selby, and P. W. Kamphuisen Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis Circulation, January 1, 2008; 117(1): 93 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. V. Gomes and S. R. Deitcher Risk of Venous Thromboembolic Disease Associated With Hormonal Contraceptives and Hormone Replacement Therapy: A Clinical Review Arch Intern Med, October 11, 2004; 164(18): 1965 - 1976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. O. Spitzer, J. M. Faith, and K. D. MacRae Myocardial infarction and third generation oral contraceptives: aggregation of recent studies Hum. Reprod., September 1, 2002; 17(9): 2307 - 2314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.R. Rosendaal, F.M. Helmerhorst, and J.P. Vandenbroucke Female Hormones and Thrombosis Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 201 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sidney, D. S. Siscovick, D. B. Petitti, S. M. Schwartz, C. P. Quesenberry, B. M. Psaty, T. E. Raghunathan, J. Kelaghan, and T. D. Koepsell Myocardial Infarction and Use of Low-Dose Oral Contraceptives : A Pooled Analysis of 2 US Studies Circulation, September 15, 1998; 98(11): 1058 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Douketis, J. S. Ginsberg, A. Holbrook, M. Crowther, E. K. Duku, and R. F. Burrows A Reevaluation of the Risk for Venous Thromboembolism With the Use of Oral Contraceptives and Hormone Replacement Therapy Arch Intern Med, July 28, 1997; 157(14): 1522 - 1530. [Abstract] [PDF]
|
|